Jodi M. Gilman

2.9k total citations
78 papers, 1.8k citations indexed

About

Jodi M. Gilman is a scholar working on Pharmacology, Cognitive Neuroscience and Epidemiology. According to data from OpenAlex, Jodi M. Gilman has authored 78 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Pharmacology, 23 papers in Cognitive Neuroscience and 18 papers in Epidemiology. Recurrent topics in Jodi M. Gilman's work include Cannabis and Cannabinoid Research (37 papers), Substance Abuse Treatment and Outcomes (16 papers) and Prenatal Substance Exposure Effects (15 papers). Jodi M. Gilman is often cited by papers focused on Cannabis and Cannabinoid Research (37 papers), Substance Abuse Treatment and Outcomes (16 papers) and Prenatal Substance Exposure Effects (15 papers). Jodi M. Gilman collaborates with scholars based in United States, United Kingdom and Philippines. Jodi M. Gilman's co-authors include Daniel W. Hommer, James M. Bjork, Vijay A. Ramchandani, A. Eden Evins, Randi M. Schuster, Katherine H. Karlsgodt, Anne J. Blood, Myung J. Lee, André van der Kouwe and John K. Kuster and has published in prestigious journals such as Science, JAMA and Journal of Neuroscience.

In The Last Decade

Jodi M. Gilman

69 papers receiving 1.8k citations

Peers

Countries citing papers authored by Jodi M. Gilman

Since Specialization

Citations

This map shows the geographic impact of Jodi M. Gilman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jodi M. Gilman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jodi M. Gilman more than expected).

Fields of papers citing papers by Jodi M. Gilman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jodi M. Gilman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jodi M. Gilman. The network helps show where Jodi M. Gilman may publish in the future.

Co-authorship network of co-authors of Jodi M. Gilman

This figure shows the co-authorship network connecting the top 25 collaborators of Jodi M. Gilman. A scholar is included among the top collaborators of Jodi M. Gilman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jodi M. Gilman. Jodi M. Gilman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prenatal Adversities and Risk of Persistent Youth Psychopathology and Altered Cortical Thinning 2026 ·JAMA Psychiatry ·Dongmei Zhi, (unknown), (unknown), (unknown), Erin C. Dunn, Phil H. Lee, (unknown), Harrison T. Reeder, Scott E. Hadland, Alysa E. Doyle, Jacqueline A. Clauss, (unknown), Joshua L. Roffman, Jodi M. Gilman	0
2	Cue-Elicited Brain Activity and Treatment Outcomes in Substance Use Disorders 2025 ·JAMA Network Open ·(unknown), (unknown), (unknown), (unknown), Hamed Ekhtiari, (unknown), Amy C. Janes, Jodi M. Gilman	0
3	Use of Tobacco Products and Suicide Attempts Among Elementary School–Aged Children 2024 ·JAMA Network Open ·Phil H. Lee, Brenden Tervo‐Clemmens, Richard T. Liu, (unknown), Jae-Yoon Jung, Amy C. Janes, Jodi M. Gilman	5
4	Intoxication due to Δ9-tetrahydrocannabinol is characterized by disrupted prefrontal cortex activity 2024 ·Neuropsychopharmacology ·(unknown), (unknown), (unknown), Kevin Potter, Gladys N. Pachas, A. Eden Evins, Jodi M. Gilman	2
5	Contingency management is associated with positive changes in attitudes and reductions in cannabis use even after discontinuation of incentives among non-treatment seeking youth 2024 ·Drug and Alcohol Dependence ·Megan Cooke, (unknown), Joanna M. Streck, Kevin Potter, (unknown), (unknown), Jodi M. Gilman, A. Eden Evins, Randi M. Schuster	2
6	Development of cannabis use disorder in medical cannabis users: A 9-month follow-up of a randomized clinical trial testing effects of medical cannabis card ownership 2023 ·Frontiers in Psychiatry ·Megan Cooke, Kevin Potter, (unknown), (unknown), Randi M. Schuster, Brenden Tervo‐Clemmens, Bettina B. Hoeppner, Gladys N. Pachas, A. Eden Evins, Jodi M. Gilman	10
7	Genetic patterning for child psychopathology is distinct from that for adults and implicates fetal cerebellar development 2023 ·Nature Neuroscience ·(unknown), Keiko Kunitoki, (unknown), (unknown), (unknown), (unknown), Kevin Dowling, Alysa E. Doyle, Erin C. Dunn, Hamdi Eryilmaz, Jodi M. Gilman, Daphne J. Holt, Eve M. Valera, Jordan W. Smoller, Charlotte A. M. Cecil, Henning Tiemeier, Phil H. Lee, Joshua L. Roffman	18
8	Resting state network connectivity is associated with cognitive flexibility performance in youth in the Adolescent Brain Cognitive Development Study 2023 ·Neuropsychologia ·Sarah A. Thomas, (unknown), Jodi M. Gilman	5
9	Cannabis use and sleep quality in daily life: An electronic daily diary study of adults starting cannabis for health concerns 2022 ·Drug and Alcohol Dependence ·Brenden Tervo‐Clemmens, William A. Schmitt, (unknown), Megan Cooke, Randi M. Schuster, (unknown), Gladys N. Pachas, A. Eden Evins, Jodi M. Gilman	12
10	Study protocol for a phase II, double-blind, randomised controlled trial of cannabidiol (CBD) compared with placebo for reduction of brain neuroinflammation in adults with chronic low back pain 2022 ·BMJ Open ·(unknown), Minhae Kim, (unknown), Nathaniel D. Mercaldo, Robert R. Edwards, Vitaly Napadow, Yi Zhang, (unknown), Zeynab Alshelh, A. Eden Evins, Marco L. Loggia, Jodi M. Gilman	3
11	State-Level Recreational Cannabis Legalization Is Not Differentially Associated with Cannabis Risk Perception Among Children: A Multilevel Regression Analysis 2022 ·Cannabis and Cannabinoid Research ·Jodi M. Gilman, (unknown), (unknown), (unknown), (unknown), Kevin Potter, Brenden Tervo‐Clemmens, Joshua L. Roffman, A. Eden Evins	0
12	Cognitive Phenotypes of HIV Defined Using a Novel Data-driven Approach 2022 ·Journal of Neuroimmune Pharmacology ·Robert Paul, (unknown), (unknown), Adam W. Carrico, Eileen Martin, Jacob Bolzenius, Patrick H. Luckett, Sarah Cooley, (unknown), Jodi M. Gilman, (unknown), Beau M. Ances	6
13	Polygenic score for cigarette smoking is associated with ever electronic‐cigarette use in a college‐aged sample 2021 ·Addiction ·Megan Cooke, (unknown), K. Elizabeth, Jodi M. Gilman, Hermine H. Maes, Roseann E. Peterson, Elizabeth Prom‐Wormley, A. Eden Evins, Randi M. Schuster, (unknown)	3
14	Association of adverse prenatal exposure burden with child psychopathology in the Adolescent Brain Cognitive Development (ABCD) Study 2021 ·PLoS ONE ·Joshua L. Roffman, (unknown), Kevin Dowling, (unknown), (unknown), Hang Lee, Hamdi Eryilmaz, Lee S. Cohen, Jodi M. Gilman, Alysa E. Doyle, Erin C. Dunn	24
15	Using Functional Near-Infrared Spectroscopy to Measure Effects of Delta 9-Tetrahydrocannabinol on Prefrontal Activity and Working Memory in Cannabis Users 2017 ·Frontiers in Human Neuroscience ·Hasan Onur Keleş, (unknown), Gladys N. Pachas, A. Eden Evins, Jodi M. Gilman	11
16	A contingency management method for 30-days abstinence in non-treatment seeking young adult cannabis users 2016 ·Drug and Alcohol Dependence ·Randi M. Schuster, (unknown), Jodi M. Gilman, Alan J. Budney, Ryan G. Vandrey, A. Eden Evins	24
17	Cannabis Use Is Quantitatively Associated with Nucleus Accumbens and Amygdala Abnormalities in Young Adult Recreational Users 2014 ·Journal of Neuroscience ·Jodi M. Gilman, John K. Kuster, Sang Lee, Myung J. Lee, Byoung Woo Kim, Nikos Makris, André van der Kouwe, Anne J. Blood, Katherine H. Karlsgodt	189
18	Subjective and Neural Responses to Intravenous Alcohol in Young Adults with Light and Heavy Drinking Patterns 2011 ·Neuropsychopharmacology ·Jodi M. Gilman, Vijay A. Ramchandani, (unknown), Daniel W. Hommer	78
19	Greater Activation in Left Hemisphere Language‐Related Regions During Simple Judgment Tasks Among Substance‐Dependent Patients in Treatment for Alcoholism 2009 ·Alcoholism Clinical and Experimental Research ·Jodi M. Gilman, (unknown), Daniel W. Hommer	21
20	Neurokinin 1 Receptor Antagonism as a Possible Therapy for Alcoholism 2008 ·Science ·David T. George, Jodi M. Gilman, Jacqueline Hersh, Annika Thorsell, David Herion, Christopher B. Geyer, Xiaomei Peng, William Kielbasa, Robert R. Rawlings, J Brandt, Donald R. Gehlert, J. Tauscher, Stephen P. Hunt, Daniel W. Hommer, Markus Heilig	168

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact